Androgen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cells.
Androgen deprivation (AD) is an effective method for initially suppressing prostate cancer (PC) progression. However, androgen-refractory PC cells inevitably emerge from the androgen-responsive tumor, leading to incurable disease. Recent studies have shown AD induces cellular senescence, a phenomeno...
Guardado en:
Autores principales: | Dominick G A Burton, Maria G Giribaldi, Anisleidys Munoz, Katherine Halvorsen, Asmita Patel, Merce Jorda, Carlos Perez-Stable, Priyamvada Rai |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e8c108d649c24e299fff0ac2f2a92555 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Metabolic changes in patients with prostate cancer with androgen deprivation therapy
por: Maxim N. Peshkov, et al.
Publicado: (2020) -
Prostate-specific antigen dynamics predict individual responses to intermittent androgen deprivation
por: Renee Brady-Nicholls, et al.
Publicado: (2020) -
The Ocular Surface Characteristics in Prostate Cancer Patients Treated with Androgen Deprivation Therapy
por: Weina Li, et al.
Publicado: (2021) -
Changes in resting-state measures of prostate cancer patients exposed to androgen deprivation therapy
por: Julio Plata-Bello, et al.
Publicado: (2021) -
Risk of esophageal and gastric adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer
por: Richard Shore, et al.
Publicado: (2021)